What is a potential adverse effect of esmolol in this setting?

Prepare for the Emergency Nursing Orientation 3.0 Cardiovascular Emergencies Test. Use interactive flashcards and detailed explanations with multiple choice questions. Enhance your understanding of cardiovascular emergencies and succeed on your exam!

Multiple Choice

What is a potential adverse effect of esmolol in this setting?

Explanation:
Esmolol blocks beta-1 receptors in the heart, which slows the firing of the SA node and slows conduction through the AV node. In a setting where you’re trying to rapidly control heart rate, the most likely adverse effect is bradycardia because the heart rate drops as the pacemaker and conduction pathways are suppressed. This can reduce cardiac output and potentially cause hypotension, so it requires careful titration and monitoring. The drug’s very short half-life (about 9 minutes) means any bradycardia is usually quickly reversible once the infusion is adjusted or stopped. Hyperkalemia isn’t a typical effect of beta-blockade, and tachycardia would be opposite the drug’s action, so it’s not expected.

Esmolol blocks beta-1 receptors in the heart, which slows the firing of the SA node and slows conduction through the AV node. In a setting where you’re trying to rapidly control heart rate, the most likely adverse effect is bradycardia because the heart rate drops as the pacemaker and conduction pathways are suppressed. This can reduce cardiac output and potentially cause hypotension, so it requires careful titration and monitoring. The drug’s very short half-life (about 9 minutes) means any bradycardia is usually quickly reversible once the infusion is adjusted or stopped. Hyperkalemia isn’t a typical effect of beta-blockade, and tachycardia would be opposite the drug’s action, so it’s not expected.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy